Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06102707
What this trial is testing

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer Recurrent
Qilu Hospital of Shandong University 50
Testing effectiveness (Phase 2)UnknownNCT03599778
What this trial is testing

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Carcinoma
Anhui Provincial Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802184
What this trial is testing

GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDAC

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
West China Hospital 45
Testing effectiveness (Phase 2)UnknownNCT04832204
What this trial is testing

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Who this might be right for
Solid Tumor
Beijing Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04547088
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 27
Testing effectiveness (Phase 2)Study completedNCT05277480
What this trial is testing

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Who this might be right for
Effect of DrugDrugToxicity
Peking University People's Hospital 81
Early research (Phase 1)UnknownNCT03645200
What this trial is testing

Treatment of Carrying TP53 Harmful Mutations

Who this might be right for
Advanced Cancer
Tianjin Medical University Second Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07026149
What this trial is testing

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06925243
What this trial is testing

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 682
Testing effectiveness (Phase 2)Looking for participantsNCT07154082
What this trial is testing

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wei Zhang 27
Testing effectiveness (Phase 2)UnknownNCT03650738
What this trial is testing

This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment

Who this might be right for
Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)UnknownNCT04006821
What this trial is testing

PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma

Who this might be right for
Gastric CancerAFP
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Not applicableUnknownNCT05653817
What this trial is testing

Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University 60
Testing effectiveness (Phase 2)UnknownNCT02829385
What this trial is testing

Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients

Who this might be right for
Colorectal Neoplasms
Shoucheng Ma 53
Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Testing effectiveness (Phase 2)UnknownNCT03609489
What this trial is testing

Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Who this might be right for
Biliary Carcinoma
First Affiliated Hospital of Guangxi Medical University 40
Testing effectiveness (Phase 2)UnknownNCT03271073
What this trial is testing

Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04459078
What this trial is testing

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Lung
Hunan Cancer Hospital 63
Next Page